Today: 20 May 2026
Browse Category

NASDAQ:RYTM 11 December 2025 - 30 December 2025

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Rhythm Pharmaceuticals shares dropped 4.2% to $107.85 in early afternoon trading Tuesday as biotech stocks broadly declined. Investors are awaiting an FDA decision on expanding Imcivree’s label, now expected by March 20, 2026. Board member Camille L. Bedrosian resigned effective immediately, according to an SEC filing. Major biotech ETFs fell over 1% while the broader market was flat.
30 December 2025
··
Rhythm Pharmaceuticals (RYTM) Hits Record High on Rare-Disease Breakthrough: Latest News, Stock Forecast and Analyst Outlook

Rhythm Pharmaceuticals (RYTM) Hits Record High on Rare-Disease Breakthrough: Latest News, Stock Forecast and Analyst Outlook

Rhythm Pharmaceuticals shares jumped over 15% to a record high near $121 on December 11 after reporting positive interim Phase 2 data for setmelanotide in Prader-Willi syndrome. Six of eight patients showed BMI reductions at three months, and most saw declines in hunger scores. The company plans a Phase 3 trial pending Phase 2 completion. RYTM stock is up around 80–90% year-to-date.
11 December 2025
·

Stock Market Today

  • Top Investor Advises Caution Ahead of Nvidia Q1 2027 Earnings
    May 20, 2026, 4:53 PM EDT. A leading investor has cautioned that it might be "time to jump ship" on Nvidia (NASDAQ:NVDA) stock ahead of its Q1 2027 earnings report. Despite strong enthusiasm among Nvidia bulls, concerns are mounting about the stock's valuation and future growth prospects. The warning signals that some investors may be re-evaluating their positions as the semiconductor firm prepares to release results that could sway market sentiment.

Latest articles

RBC Stock Tops 52-Week High Ahead of May 28

RBC Stock Tops 52-Week High Ahead of May 28

20 May 2026
Royal Bank of Canada shares hit a 52-week high of C$257.91 on Wednesday, closing up 1.99% at C$257.55. Fitch upgraded RBC’s legacy senior long-term debt rating to AA+ from AA on May 19. Investors await RBC’s second-quarter results, set for May 28. The S&P/TSX Composite Index rose 0.9% as most sectors advanced.
Arm Jumps 15% as AI CPU Trade Picks Up

Arm Jumps 15% as AI CPU Trade Picks Up

20 May 2026
Arm’s U.S.-listed ADRs jumped 15.1% to $256.73 on Wednesday after Bernstein initiated coverage with an outperform rating and $300 target. The rally came ahead of Nvidia’s results and amid a broader chip stock surge. Arm reported record quarterly revenue and strong demand for its new AGI CPU. Ongoing U.S. antitrust scrutiny and supply constraints remain concerns.
Reddit Pushes Past $150 but Ad Campaign Still Lags

Reddit Pushes Past $150 but Ad Campaign Still Lags

20 May 2026
Reddit shares fell 5.2% to $146.84 late Wednesday, underperforming broader tech indexes despite launching new app-advertising tools. A trust linked to CEO Steve Huffman sold 18,000 shares last week, according to an SEC filing. Reddit reported Q1 revenue of $663 million, up 69% year over year, and set Q2 revenue guidance between $715 million and $725 million.
Go toTop